Almira Sciences, Inc 13D filing

CHICAGO, Dec. 11, 2019 /PRNewswire/ -- Ronald L Chez, a private investor, files a 13D for Alimera Sciences, Inc. ALIM. Alimera returns to growth in the 3^rd quarter and expects continued progress in the 4^th quarter. The Company is in a strong position to succeed with their unique approach to DME.

Media contact: Elias Matsakis, Holland & Knight LLP

SOURCE Ronald L. Chez, Inc.